Scientific publications

Journal of Affective Disorders, 2024

Multi-omics combined to investigate potential druggable therapeutic targets for stroke: A systematic Mendelian randomization study and transcriptome verification

Shi Y., Bao L., Li Y. et al.

Scientific Reports, 2024

Plasma proteomics and lipidomics facilitate elucidation of the link between Alzheimer's disease development and vessel wall fragility

Tokuoka S., Hamano F., Kobayashi A. et al.

PLOS ONE, 2024

Is there a causal relationship between resistin levels and bone mineral density, fracture occurrence? A mendelian randomization study

Xu T., Li C., Liao Y. et al.

Journal of Experimental Medicine, 2024

Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer

Tsimberidou A., Alayli F., Okrah K. et al.

European Journal of Heart Failure, 2024

Association of ventricular–arterial coupling with biomarkers involved in heart failure pathophysiology – the STANISLAS cohort

Holm H., Magnusson M., Jujić A. et al.

Schizophrenia, 2024

Elevated plasma matrix metalloproteinase 9 in schizophrenia patients associated with poor antipsychotic treatment response and white matter density deficits

Li X., Wang X., Yang Y. et al.

Nature Neuroscience, 2024

Proteomic changes in Alzheimer’s disease associated with progressive Aβ plaque and tau tangle pathologies

Pichet Binette A., Gaiteri C., Wennström M. et al.

Frontiers in Immunology, 2024

An exploratory clinical study of β-glucan combined with camrelizumab and SOX chemotherapy as first-line treatment for advanced gastric adenocarcinoma

Chu Y., He X., Xue Y. et al.

Cell Host & Microbe, 2024

RSV and rhinovirus increase pneumococcal carriage acquisition and density, whereas nasal inflammation is associated with bacterial shedding

Mitsi E., Nikolaou E., Goncalves A. et al.

Nature Communications, 2024

Tislelizumab plus cetuximab and irinotecan in refractory microsatellite stable and RAS wild-type metastatic colorectal cancer: a single-arm phase 2 study

Xu X., Ai L., Hu K. et al.

Frontiers in Neuroscience, 2024

Lectin-type oxidized LDL receptor-1 as a potential therapeutic target for cerebral cavernous malformations treatment

Ashok K., Martinez T., Sesen J. et al.

European Heart Journal, 2024

Dapagliflozin, peptide YY, and weight loss in heart failure with preserved ejection fraction

Reddy Y., Melenovsky V., Asokan A. et al.

Cardiovascular Research, 2024

Smooth muscle-specific deletion of cellular communication network factor 2 causes severe aorta malformation and atherosclerosis

Larsen J., Hegelund J., Pedersen M. et al.

Nature Communications, 2024

Non-human primate model of long-COVID identifies immune associates of hyperglycemia

Palmer C., Perdios C., Abdel-Mohsen M. et al.

Cell Metabolism, 2024

Obesity intensifies sex-specific interferon signaling to selectively worsen central nervous system autoimmunity in females

Cordeiro B., Ahn J., Gawde S. et al.

Frontiers in Immunology, 2024

Comprehensive landscapes of the causal network between immunity and sarcopenia

Liu M., Wang J., Han Y. et al.

Nature Communications, 2024

A roadmap to the molecular human linking multiomics with population traits and diabetes subtypes

Halama A., Zaghlool S., Thareja G. et al.

Clinical Cancer Bulletin, 2024

Causal associations of plasma proteins with lung squamous cell carcinoma risk: a proteome-wide Mendelian randomization and colocalization analysis

Wang Q., Xue X., Ling X. et al.

Journal of Bone and Mineral Metabolism, 2024

Olink and gut microbial metabolomics reveal new biomarkers for the prediction and diagnosis of PMOP

Wu R., Wu J., Jin H. et al.

Journal of Neuroinflammation, 2024

The differential proteomic response to ischemic stroke in appalachian subjects treated with mechanical thrombectomy

McLouth C., Maglinger B., Frank J. et al.